This study demonstrated that TAK-242 administration reduced serum LPS and inflammatory cytokine concentrations, reversed microbiota dysbiosis in HF rats, downregulated TLR4, P-IKBα and P-p65 protein expression in the TLR4/NF-κB pathway. This evidence concerns the gene NFKB1 and hydrops fetalis.